tradingkey.logo
tradingkey.logo
Search

VivoSim Labs Ord Shs

VIVS
Add to Watchlist
0.155USD
+0.026+20.16%
Close 11-11 16:00(ET)
2.57MMarket Cap
0.09P/E TTM
After-hours 19:18 (ET)0.150USD-0.001-0.66%

About VivoSim Labs Ord Shs Company

VivoSim Labs, Inc. is a pharmaceutical and biotechnology services company that is focused on providing testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine. The Company offers partners liver and intestinal toxicology insights using its new approach methodologies (NAM) models. The Company offers liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development. It uses its proprietary technologies to build functional 3D human tissues that mimic key aspects of native human tissue composition, architecture, function, and disease. The Company's 3D human tissue platform is multifaceted. The Company has expertise in 3D organoids, such as spheroids, and has made advances in proprietary cell culture techniques including ratios, components and conditions.

VivoSim Labs Ord Shs Profile

Ticker Symbol- -
Company name- -
IPO date- -
CEO- -
Number of employees- -
Security type- -
Fiscal year-end- -
Address- -
City- -
Stock exchange- -
Country- -
Postal code- -
Phone- -
Website- -
Ticker Symbol- -
IPO date- -
CEO- -

Company Executives of VivoSim Labs Ord Shs

Name
Name/Position
Position
Shareholding
Change
Mr. Keith E. Murphy
Mr. Keith E. Murphy
Executive Chairman of the Board, Corporate Secretary
Executive Chairman of the Board, Corporate Secretary
27.09K
+55.37%
Mr. Douglas Jay Cohen
Mr. Douglas Jay Cohen
Lead Independent Director
Lead Independent Director
20.90K
+71.77%
Mr. Tony Lialin
Mr. Tony Lialin
Chief Commercial Officer
Chief Commercial Officer
20.00K
--
Ms. Alison Tjosvold Milhous
Ms. Alison Tjosvold Milhous
Independent Director
Independent Director
19.90K
+75.38%
Mr. David Gobel
Mr. David Gobel
Independent Director
Independent Director
15.00K
--
Mr. Adam K. Stern
Mr. Adam K. Stern
Independent Director
Independent Director
--
--
Mr. Norman Staskey
Mr. Norman Staskey
President, Chief Financial Officer
President, Chief Financial Officer
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Keith E. Murphy
Mr. Keith E. Murphy
Executive Chairman of the Board, Corporate Secretary
Executive Chairman of the Board, Corporate Secretary
27.09K
+55.37%
Mr. Douglas Jay Cohen
Mr. Douglas Jay Cohen
Lead Independent Director
Lead Independent Director
20.90K
+71.77%
Mr. Tony Lialin
Mr. Tony Lialin
Chief Commercial Officer
Chief Commercial Officer
20.00K
--
Ms. Alison Tjosvold Milhous
Ms. Alison Tjosvold Milhous
Independent Director
Independent Director
19.90K
+75.38%
Mr. David Gobel
Mr. David Gobel
Independent Director
Independent Director
15.00K
--
Mr. Adam K. Stern
Mr. Adam K. Stern
Independent Director
Independent Director
--
--

FAQs

Who are the top five shareholders of VivoSim Labs Ord Shs?

The top five shareholders of VivoSim Labs Ord Shs are: Mr. Keith E. Murphy
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.